Mutations in the glycine receptor α1 subunit (GLRA1) gene in hereditary hyperekplexia pedigrees: evidence for non-penetrance of mutation Y279C
Open Access
- 1 June 2001
- journal article
- letter
- Published by BMJ in Journal of Medical Genetics
- Vol. 38 (6) , e17
- https://doi.org/10.1136/jmg.38.6.e17
Abstract
The first pedigree (Fam-1) contains 20 members over three generations with 10 affected subjects (fig 1A). The female proband (III.13) from family 1 was prone to fall in response to any unexpected stimulus, such as a touch or a sharp sound, from the time she started walking. Falling was the result of momentary generalised stiffness of her trunk and limbs with loss of postural control. This symptom was present in a large number of male and female relatives, as shown in fig1A, consistent with autosomal dominant inheritance of the disorder. Falling in affected members of the family was sudden, unpredictable, and uncontrollable. Falling was not accompanied by loss of consciousness and affected members were able to rise from the ground immediately after falling. The diagnosis of hyperekplexia was made after publication of the paper by Morley et al.10 The proband was treated with clonazepam and remained symptomless for over 13 years.Keywords
This publication has 13 references indexed in Scilit:
- Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutationsAnnals of Neurology, 1999
- The frameshift mutation oscillator (Glra1spd-ot) produces a complete loss of glycine receptor α1-polypeptide in mouse central nervous systemNeuroscience, 1997
- Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channelThe EMBO Journal, 1997
- A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsyNature Genetics, 1995
- Mutational analysis of familial and sporadic hyperekplexiaAnnals of Neurology, 1995
- Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonistsNeuron, 1995
- Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the α1 subunit of the inhibitory glycine receptorHuman Molecular Genetics, 1994
- Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexiaNature Genetics, 1993
- Startle disease, or hyperekplexia: Response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysisAnnals of Neurology, 1992
- Hyperexplexia: an inherited disorder of the startle responseClinical Genetics, 1982